IWC
APRE icon

Integrated Wealth Concepts’s Aprea Therapeutics APRE Stock Holding History

Integrated Wealth Concepts’s Portfolio APRE Stock Details APRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$36 Buy
+46
New +$38 ﹤0.01% 5857

Other funds holding APRE

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
DP
Diadema Partners Morristown, New Jersey $791M AUM 245.83% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Integrated Wealth Concepts's APRE Position: Q2 2026 in Review

Integrated Wealth Concepts opened a new position in Aprea Therapeutics (APRE) in Q2 2026: 46 shares worth $36. The stake represents ﹤0.01% of the portfolio and ranks #5857 among its holdings.

28 funds tracked by Wall St. Rank hold APRE as of Q2 2026.

  • Integrated Wealth Concepts held 46 shares of Aprea Therapeutics worth $36 as of Q2 2026.
  • Aprea Therapeutics was a new Integrated Wealth Concepts position in Q2 2026.
  • Aprea Therapeutics made up ﹤0.01% of Integrated Wealth Concepts's portfolio in Q2 2026, its #5857 holding.
  • 28 funds tracked by Wall St. Rank held Aprea Therapeutics as of Q2 2026.

Based on Integrated Wealth Concepts's 13F filing for Q2 2026, filed 12 Aug 2026.